5.3. Transparency of measures regulating the prices of medicinal products for human use ***I (vote)

Verbatim reports

Report on the proposal for a directive of the European Parliament and of the Council relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of public health insurance systems [COM(2012)0084 - C7-0056/2012- 2012/0035(COD)] - Committee on the Environment, Public Health and Food Safety. Rapporteur: Antonyia Parvanova (A7-0015/2013)

(Simple majority)
(Voting record: 'Results of votes', Item 3)

COMMISSION PROPOSAL

Approved as amended (P7_TA(2013)0039)

DRAFT LEGISLATIVE RESOLUTION

Adopted (P7_TA(2013)0039)

The following had spoken:

Alda Sousa had presented an oral amendment to amendment 7.

As more than 40 Members objected to the oral amendment, it was not incorporated.

Antonyia Parvanova (rapporteur), after the vote, to ask what the Commission's position on the amendments adopted was, and Maroš Šefčovič (Vice-President of the Commission).

°
° ° °

The following spoke: Hannes Swoboda, concerning certain remarks made by Nigel Farage during the previous debate.

(The sitting, adjourned at 11.55 prior to the formal sitting, resumed at 12.05)

IN THE CHAIR: Martin SCHULZ
President